Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats

References

• Aumst, R., and McCALLum, R. W., 1983, Metoclopramide: pharmacology and clinical application. Annals of Internal Medicine, 98, 86–95.
   PubMedGoogle Scholar
• CHAVANY, C., LE DOAN, T., COUVREUR, P., PUISIEUX, F., and HELENE, C., 1992, Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligo-nucleotides. Pharmaceutical Research, 9, 441–449.
   PubMedGoogle Scholar
• COUVREUR, P., KANTE, B., LENAERTS, V., SCAILTEUR, V., ROLAND, M., and SPEISER, P., 1980, Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. Journal of Pharmaceutucal Sciences, 69, 199–202.
   PubMedGoogle Scholar
• COUVREUR, P., KANTE, B. ROLAND, M., GUIOT, P., BAUDUIN, P., and SPEISER, P., 1979, Polycyanoacrylate nanoparticles as potential lysomotropic carriers: preparation, morphological and sorptive properties. Journal of Pharmacy and Pharmacology, 31, 311–332.
   Google Scholar
• CUTLER, D. J., 1978, Theory of the mean absorption time, an adjunct to conventional bioavailability studies. Journal of Pharmacy and Pharmacology, 30, 476–478. DONBROW, M., 1991, Microcapsules and Nanoparticles in Medicine and Pharmacy (Boca Raton, Ann Arbor, London: CRC Press).
   Google Scholar
• FRESTA, M., PUGLISI, G., GIAMMONA, G., CAVALLARO, G., MICALI, N., and FURNERI, P. M., 1995, Pefloxacin mesilate- and ofloxacin-loaded polyethylcyanoacrylate nano-particles: characterization of the colloidal drug carrier formulation. Journal of Pharmaceutical Sciences, 84, 895–902.
   PubMedGoogle Scholar
• GAREWAL, H. S., and DALTON, W. S., 1985, Metoclopramide in vincristine-induced ileus. Cancer Treatment Report, 69, 1309–1311.
   PubMedGoogle Scholar
• GARNICK, M. B., 1983, Oral metoclopramide and cisplatin chemotherapy. Annals of Internal Medicine, 99, 127.
   PubMedGoogle Scholar
• GIBALDI, M., 1991, Biopharmaceutics and Clinical Pharmacokinetic (Phildelphia, London: Lea and Febiger).
   Google Scholar
• GIBALDI, M., and PERRIER, D., 1982, Pharmacokinetics, 2nd edn (New York: Marcel Dekker).
   Google Scholar
• GRALLA, R. J., 1983, Metoclopramide: a review of antiemetic trials. Drugs, 25\(suppl 1), 63–73. GUIOT, P., and COUVREUR, P., 1986, Polymeric nanoparticles and microspheres (Boca Raton, FL: CRC Press).
   Google Scholar
• GUISE, V., DROUIN, J. Y., BENOIT, J., MAHULEAN, J., DU1VUNT, P., and COUVREUR, P., 1990, Vidarabin-loaded nanoparticles: a physicochemical study. Pharmaceutical Research, 7, 736–741.
   Google Scholar
• ILum, L., JoNEs, P. D. E., BALDWIN, R. W., and DAVIS, S. S., 1984, Tissue distribution of poly(hexy1-2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts. Journal of Pharmacology and Experimental Therapeutics, 230, 733–736.
   PubMedGoogle Scholar
• JAMES, W. B., and MELROSE, A. G., 1969, Metoclopramide in gastrointestial radiology. Clinical Radiology, 20, 57.
   PubMedGoogle Scholar
• KREUTER, J., 1983, Evaluation of nanoparticles as drug delivery systems I: preparation methods. Pharmaceutica Acta Helvetiae, 58, 196–208.
   Google Scholar
• KREUTER, J., and HARTMANN, H. R., 1983, Comparative study on the cytostatic effects and tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyano-acrylate nanoparticles in sarcoma 180-bearing mice. Oncology, 40, 363–366.
   PubMedGoogle Scholar
• KREUTER, J., TRUBER, U., and ILL', V., 1979, Distribution and elimination of poly(methy1-2-l4C methacylate) nanoparticles radioactivity after injection in rats and mice. Journal of Pharmaceutical Sciences, 68, 1443–1447.
   Google Scholar
• LEU, D., MANTHEY, B., KREUTER, J., SPEISER, P., and DELucA, P. P., 1984, Distribution and elimination of coated-polymethyl [2-14C] methacylate nanoparticles after intravenous injection in rats. Journal of Pharmaceutical Sciences, 73, 1433–1437.
   PubMedGoogle Scholar
• MACCUMBER, M. JAFFE, G., and McCuEN, B., 1996, Treatment of migraine headache after ocular surgery with intravenous metoclopramide hydrochloride. American Journal of Opthalmology,, 121, 96–97.
   Google Scholar
• MONZA DA SILVEIRA, A., PONCHEL, G., PuisrEux, F., and DUCHENE, D., 1998, Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharmaceutical Research, 15, 1051–1055.
   PubMedGoogle Scholar
• Puomsi, G., GIAMMONA, G., FRESTA, M., CALISI, B., MICALI, N., and VILLARI, A., 1993, Evaluation of polyalkylcyanoacrylate nanoparticles as a potential drug carrier: preparation, morphological characterization and loading capacity. Journal of Microencapsulation, 10, 353–366.
   PubMedGoogle Scholar
• RADWAN, M. A., 1995, In vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug delivery system of theophylline. Drug Development and Industrial Pharmacy, 21, 2371–2375.
   Google Scholar
• RADWAN, M. A., 1998, Determination of metoclopramide in serum by HPLC assay and its application to pharmacokinetic study in rat. Analytical Letters, 31, 2397–2410.
   Google Scholar
• RADWAN, M. A., ALY, Z. H., and ZAGHLOUL, I. Y., 1999, In vivo performance of parenteral theophylline- loaded polyisobutylcyanoacrylate nanoparticles in rats. European Journal of Pharmaceutical Sciences, 8, 95–98.
   PubMedGoogle Scholar
• SENG, K. T., TIONG, C. E., and HIANG, T. C., 1994, Anti-emetic effect of high dose metoclopramide vs alizapride—a randomized crossover study. British Journal of Clinical Pharmacology, 38, 282–284.
   PubMedGoogle Scholar
• TAM, Y. K., AXELSON, J. E., MCERLANE, B., KAHL, R. P., Riggs, K. W., ONGLEY, R., and PRICE, J. D. E., 1981, The pharmacokinetics of metoclopramide in rats with experimental renal and hepatic dysfunction. Journal of Pharmacology and Experimental Therapeutics, 218, 141–147.
   Google Scholar
• TENG, L., BRUCE, R. B., and DUNNING, L. K., 1977, Metaclopramide metabolism and determination by high-pressure liquid chromatography. Journal of Pharmaceutical Sciences, 66, 1615–1618.
   PubMedGoogle Scholar